Effects of Hormone Replacement Therapy on the Circadian Pattern of Atherothrombotic Risk Factors
- 15 October 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (8) , 876-880
- https://doi.org/10.1016/s0002-9149(96)00460-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.Heart, 1993
- Modifiers of timing and possible triggers of acute myocardial infarction in the thrombolysis in myocardial infarction phase II (TIMI II) study groupJournal of the American College of Cardiology, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Subgroups of patients with atypical circadian patterns of symptom onset in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Circadian distribution in fatal pulmonary thromboembolismThe American Journal of Cardiology, 1989
- Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).Circulation, 1989
- Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeThe American Journal of Cardiology, 1988
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Diurnal Variation of and Activity during the Onset of StrokeNeurosurgery, 1985
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985